纳指生物科技ETF(513290)
动态评分: 5.70分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2024-12-31 | SVRA | Savara Inc | 80.31 | 0.05% |
2024-12-31 | TERN | Terns Pharmaceuticals Inc | 71.72 | 0.05% |
2024-12-31 | MNMD | Mind Medicine (MindMed) Inc | 77.79 | 0.05% |
2024-12-31 | ALT | Altimmune Inc | 78.16 | 0.05% |
2024-12-31 | ATXS | Astria Therapeutics Inc | 76.9 | 0.05% |
2024-12-31 | TBPH | Theravance Biopharma Inc | 70.53 | 0.05% |
2024-12-31 | TRML | Tourmaline Bio Inc | 79.26 | 0.05% |
2024-12-31 | PACB | Pacific Biosciences of California Inc | 76.39 | 0.05% |
2024-12-31 | RNAC | Cartesian Therapeutics Inc | 69.38 | 0.05% |
2024-12-31 | CRMD | CorMedix Inc | 74.91 | 0.05% |
2024-12-31 | XERS | Xeris制药 | 77.03 | 0.05% |
2024-12-31 | VERV | Verve Therapeutics Inc | 72.78 | 0.05% |
2024-12-31 | EYPT | EyePoint Pharmaceuticals Inc | 77.5 | 0.05% |
2024-12-31 | ANNX | Annexon Inc | 83.35 | 0.05% |
2024-12-31 | THRD | Third Harmonic Bio Inc | 70.67 | 0.05% |
2024-12-31 | ARCT | Arcturus Therapeutics Holdings Inc | 70.07 | 0.05% |
2024-12-31 | MGTX | MeiraGTx Holdings plc | 72.54 | 0.05% |
2024-12-31 | ALMS | Alumis Inc | 56.57 | 0.04% |
2024-12-31 | PRME | Prime Medicine Inc | 58.38 | 0.04% |
2024-12-31 | MXCT | MaxCyte Inc | 66.88 | 0.04% |
公告&资料
